| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 39,334 | 10,743 | ||
| Grant receivables | 1,900 | 6,285 | ||
| Prepaid expenses and other current assets | 1,160 | 1,207 | ||
| Restricted cash equivalents | 489 | 814 | ||
| Total current assets | 42,883 | 19,049 | ||
| Property and equipment, net | 159 | 174 | ||
| Right-of-use assets, operating leases | 353 | 399 | ||
| Total assets | 43,395 | 19,622 | ||
| Accounts payable | 827 | 771 | ||
| Accrued expenses | 3,923 | 9,372 | ||
| Other current liabilities | - | 41 | ||
| Deferred grant income, current | 1,736 | 1,982 | ||
| Operating lease liabilities, current | 168 | 198 | ||
| Total current liabilities | 6,654 | 12,364 | ||
| Operating lease liabilities, non-current | 212 | 229 | ||
| Total liabilities | 6,866 | 12,593 | ||
| Common stock, 0.001 par value, 250,000,000 shares authorized 88,268,078 and 59,854,877 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 88 | 65 | ||
| Additional paid-in capital | 231,745 | 197,338 | ||
| Accumulated deficit | -195,304 | -190,374 | ||
| Total stockholders' equity | 36,529 | 7,029 | ||
| Total liabilities and stockholders' equity | 43,395 | 19,622 | ||
COGNITION THERAPEUTICS INC (CGTX)
COGNITION THERAPEUTICS INC (CGTX)